Oxygen can refresh your strategy with a structured process of environmental assessment and review, to breathe new life into operational and tactical plans. Oxygen can also bring a new perspective and up-to-the-minute intelligence on current changes to the European healthcare policy sector.
Oxygen’s experience and expertise can help clients understand and influence the political and decision-making environment to align their objectives with the direction of health policy.
At Oxygen we don’t want to simply “move the needle”. We’ve developed an approach to public affairs based on big picture and aspirational thinking, with a vision to save lives and improve quality of life.
We don’t want to just lobby about change. We want to make change happen.
In recent years there has been a shift in the way life science companies gain market access. It has resulted in a commercial climate of managed access, where payers want to test new products in the real world before they decide how much they want to pay for them.
Previous pathways to market via research and clinical trials, to licensing and reimbursement, no longer guarantee commercial success. Oxygen can help open new avenues for clients to gain market access and accelerate uptake.